Enlipsium

Enabling new x-ray resolution with nano-scintillators

Enlipsium is revolutionizing cancer treatment with its groundbreaking dosimetry system for radiation therapy and advanced X-ray imaging. The ultra-high resolution system enables precise dose mapping, which improves treatment accuracy and patient outcomes. With a complete solution comprising hardware, software, and consumables, Enlipsium offers superior efficiency and cost-effectiveness. Already deployed at leading cancer centers, the innovation promises to transform personalized cancer care, minimizing side effects and enhancing quality of life for patients worldwide.

Enlipsium logo

WEBSITE
enlipsium.com

CO-FOUNDER & CEO
Yzhar Perry

FROM
Singapore
Israel

SOCIAL